VOYA Investment Management
SLXP

VOYA Investment Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

VOYA Investment Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-113,293
Closed -$13M – 2592
2014
Q4 		$13M Buy
113,293
+7,543
+7% +$914K 0.03% 503
2014
Q3 		$16.5M Sell
105,750
-25,149
-19% -$3.65M 0.04% 412
2014
Q2 		$16.1M Sell
130,899
-21,824
-14% -$2.41M 0.04% 432
2014
Q1 		$15.8M Buy
152,723
+7,474
+5% +$765K 0.04% 436
2013
Q4 		$13.1M Sell
145,249
-25,820
-15% -$2.06M 0.03% 491
2013
Q3 		$11.4M Sell
171,069
-5,342
-3% -$368K 0.03% 516
2013
Q2 		$11.7M Buy
+176,411
New +$10.1M 0.03% 486

Other funds holding SLXP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VOYA Investment Management's SLXP Position: Q1 2015 in Review

VOYA Investment Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 113,293 shares — an estimated $13M sold.

VOYA Investment Management first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $16.5M in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

  • VOYA Investment Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
  • VOYA Investment Management sold 113,293 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $13M.
  • VOYA Investment Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
  • VOYA Investment Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $16.5M in Q3 2014.
  • 298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on VOYA Investment Management's 13F filing for Q1 2015, filed 15 May 2015.